Spain remains one of the largest markets in Europe yet to legalise medical cannabis. Cannabis Europa Madrid will discuss federal roadblocks to legislation, European trends and the latest research and innovation in the Spanish capital.
Announcing: Cannabis Europa London
Pioneering researchers and academics are overhauling our understanding of medical cannabis. As the knowledge base and data set develops, a seismic shift in public opinion is occurring at a global scale, resulting in progressive legislation, high-quality cannabis-based medicines and transformative commercial opportunities.
Cannabis continues to make headlines across Europe as new countries look to push forward medical cannabis programmes and unlock the societal and commercial potential of this formerly stigmatised plant. At the other end of the spectrum, consumer interest in CBD continues to skyrocket, disrupting mainstream industries from food and drink to wellness and beauty.
These rapidly emerging changes are triggering new conversations in Europe that bring about pertinent questions: How will we view cannabis in 2050? Will cannabinoid-based medicines be another standard in modern healthcare systems? Will CBD remain a novel food in the EU? Will Luxembourg become a model for the regulation of cannabis like Denmark has become for medical cannabis?
Cannabis Europa London invites you to join policymakers, pioneers and innovators on June 22 – 23, 2020, at London’s iconic Southbank Centre to help shape the future of medical cannabis.
Cannabis Europa is delighted to announce that we will be co-hosting the Australian Medicinal Cannabis Conference 2020 in partnership with Pharmout, taking place 23-24th March in Melbourne. Industry leading investors, medical professionals and key stakeholders from across the Oceania region will be attending to discuss the future of the cannabis industry, as well as the greatest commercial opportunities expected to develop in the coming years.